A study in humans with coronary artery disease identified the miR-216b-3p as significantly downregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention, demonstrating its association with thrombotic risk [Onuoha et al. DOI:10.1111/cts.13307].